Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in ANCA Vasculitis Evaluation
NCT04316494Phase 4Terminated
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Dec 2020
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Dec 2020; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT04316494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04316494.